Old Web
English
Sign In
Acemap
>
authorDetail
>
Adam Matthew Petrich
Adam Matthew Petrich
Daiichi Sankyo
Medicine
non-small cell lung cancer (NSCLC)
Docetaxel
Internal medicine
treatment options
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized, phase 3 study of datopotamab deruxtecan (Dato-DXd; DS-1062) versus docetaxel in previously treated advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations (TROPION-Lung01).
2021
Journal of Clinical Oncology
Kiyotaka Yoh
Yasushi Goto
Michael Thomas
Alexander I. Spira
Jacob Sands
Melissa Lynne Johnson
Jonathan Greenberg
Adam Matthew Petrich
Ferdinand M. Guevara
Penny Phillips
Ekaterine Alexandris
Jessie Gu
Yong Zhang
Dale Shuster
Aaron Lisberg
Show All
Source
Cite
Save
Citations (1)
TROPION-PanTumor01: Dose analysis of the TROP2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd, DS-1062) for the treatment (Tx) of advanced or metastatic non-small cell lung cancer (NSCLC).
2021
Journal of Clinical Oncology
Funda Meric-Bernstam
Alexander I. Spira
Aaron Lisberg
Jacob Sands
Noboru Yamamoto
Melissa Lynne Johnson
Kiyotaka Yoh
Edward B. Garon
Rebecca S. Heist
Adam Matthew Petrich
Jonathan Greenberg
Naoyuki Tajima
Yui Kawasaki
Jessie Gu
Fumiaki Kobayashi
Yasong Lu
Ferdinand M. Guevara
Toshio Shimizu
Show All
Source
Cite
Save
Citations (2)
1